Burning Rock Biotech (BNR) Short Interest Ratio & Short Volume $4.64 +0.04 (+0.87%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Burning Rock Biotech Short Interest DataBurning Rock Biotech (BNR) has a short interest of 84,000 shares, representing 0.99% of the float (the number of shares available for trading by the public). This marks a -30.17% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.7, indicating that it would take 2.7 days of the average trading volume of 21,566 shares to cover all short positions.Current Short Interest84,000 sharesPrevious Short Interest120,300 sharesChange Vs. Previous Month-30.17%Dollar Volume Sold Short$236,040.00Short Interest Ratio2.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares10,240,000 sharesFloat Size8,490,000 sharesShort Percent of Float0.99%Today's Trading Volume3,680 sharesAverage Trading Volume21,566 sharesToday's Volume Vs. Average17% Short Selling Burning Rock Biotech? Sign up to receive the latest short interest report for Burning Rock Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBNR Short Interest Over TimeBNR Days to Cover Over TimeBNR Percentage of Float Shorted Over Time Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Burning Rock Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202484,000 shares $236,040.00 -30.2%1.0%2.7 $2.81 10/15/2024120,300 shares $347,667.00 +183.1%1.4%4.4 $2.89 9/30/202442,500 shares $138,975.00 +2.2%0.5%3.1 $3.27 9/15/202441,600 shares $148,512.00 +2.0%0.5%6.8 $3.57 8/31/202440,800 shares $216,036.00 +2.8%0.5%7.7 $5.30 8/15/202439,700 shares $247,728.00 -5.3%0.5%6.7 $6.24 Get the Latest News and Ratings for BNR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Burning Rock Biotech and its competitors with MarketBeat's FREE daily newsletter. 7/31/202441,900 shares $308,384.00 +1.2%0.5%8.2 $7.36 7/15/202441,400 shares $298,080.00 +5.1%0.5%7 $7.20 6/30/202439,400 shares $254,019.68 -4.1%0.5%6.9 $6.45 6/15/202441,100 shares $316,881.00 +2.0%0.5%7.8 $7.71 5/31/202440,300 shares $311,519.00 -26.3%0.5%7.5 $7.73 5/15/202454,700 shares $440,335.00 -86.4%0.6%11.4 $8.05 4/30/2024402,400 shares $303,852.24 +1.1%0.5%7.8 $0.76 4/15/2024397,900 shares $318,320.00 -1.9%0.5%8.2 $0.80 3/31/2024405,400 shares $295,171.74 -1.2%0.5%6.2 $0.73 3/15/2024410,300 shares $279,004.00 +2.7%0.5%5.7 $0.68 2/29/2024399,500 shares $340,493.85 -0.5%0.5%5.5 $0.85 2/15/2024401,600 shares $325,296.00 -8.1%0.5%5.4 $0.81 1/31/2024437,000 shares $375,820.00 -25.0%0.5%6 $0.86 1/15/2024582,600 shares $541,818.00 +29.1%0.7%8.2 $0.93 12/31/2023451,300 shares $419,709.00 +2.8%0.5%8.1 $0.93 12/15/2023439,000 shares $329,381.70 -6.9%0.5%8.6 $0.75 11/30/2023471,600 shares $391,428.00 -0.9%0.6%7.9 $0.83 11/15/2023476,000 shares $448,439.60 -7.2%0.6%8.8 $0.94 10/31/2023512,700 shares $489,013.26 -6.7%0.6%9.9 $0.95 10/15/2023549,500 shares $560,490.00 -6.3%0.7%8.5 $1.02 9/30/2023586,700 shares $569,099.00 -6.4%0.7%9.1 $0.97 9/15/2023626,800 shares $626,800.00 +18.2%0.7%9.8 $1.00 8/31/2023530,500 shares $718,827.50 -7.6%0.6%8.9 $1.36 8/15/2023574,100 shares $866,891.00 -5.0%0.7%10.8 $1.51 7/31/2023604,500 shares $1.09 million -0.2%0.7%11.4 $1.80 7/15/2023605,600 shares $1.30 million -2.5%0.7%16.6 $2.14 6/30/2023621,000 shares $1.34 million -2.1%0.7%15.3 $2.15 6/15/2023634,400 shares $1.39 million -4.6%0.8%12.4 $2.19 5/31/2023665,100 shares $1.74 million +9.4%0.8%11.4 $2.61 5/15/2023608,200 shares $1.73 million -17.4%0.7%8.2 $2.85 4/30/2023736,000 shares $2.29 million -7.1%0.9%8.4 $3.11 4/15/2023791,900 shares $2.29 million -5.9%0.9%7.1 $2.89 3/31/2023841,100 shares $2.36 million +4.0%N/A6.5 $2.81 3/15/2023809,100 shares $2.40 million -17.4%N/A5.4 $2.972025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] 2/28/2023979,200 shares $3.19 million -8.5%N/A5.5 $3.26 2/15/20231,070,000 shares $3.22 million -13.0%N/A5.5 $3.01 1/31/20231,230,000 shares $3.58 million -17.5%1.4%5.6 $2.91 1/15/20231,490,000 shares $5.04 million -6.3%1.7%6.6 $3.38 12/30/20221,590,000 shares $3.58 million -2.5%1.8%7 $2.25 12/15/20221,630,000 shares $4.52 million -11.9%1.9%6.2 $2.77 11/30/20221,850,000 shares $4.64 million -1.1%2.1%5.6 $2.51 11/15/20221,870,000 shares $4.26 million No Change2.2%5 $2.28 10/31/20221,870,000 shares $3.85 million -2.1%2.2%4.6 $2.06 10/15/20221,910,000 shares $4.13 million -1.6%2.2%4.5 $2.16 9/30/20221,940,000 shares $4.64 million +2.7%2.3%4.2 $2.39 9/15/20221,890,000 shares $6.24 million +18.9%2.2%3 $3.30 8/31/20221,590,000 shares $6.23 million +34.8%1.8%1.9 $3.92 8/15/20221,180,000 shares $4.65 million +18.3%1.4%1.5 $3.94 7/31/2022997,900 shares $3.18 million +9.7%1.2%1.2 $3.19 7/15/2022909,700 shares $2.90 million +70.9%1.1%1.1 $3.19 6/30/2022532,200 shares $1.55 million +39.2%0.6%0.7 $2.91 6/15/2022382,300 shares $791,361.00 -15.9%0.4%0.6 $2.07 5/31/2022454,600 shares $1.09 million -53.6%0.5%1.2 $2.40 5/15/2022980,500 shares $3.26 million -19.0%1.1%3.2 $3.32 4/30/20221,210,000 shares $6.67 million -4.0%1.4%4.7 $5.51 4/15/20221,260,000 shares $9.11 million -6.0%1.5%4.6 $7.23 3/31/20221,340,000 shares $12.45 million +3.9%1.6%4.8 $9.29 3/15/20221,290,000 shares $8.64 million +4.9%1.5%4.7 $6.70 2/28/20221,230,000 shares $10.37 million +5.1%1.4%4.3 $8.43 2/15/20221,170,000 shares $9.73 million +5.4%1.4%3 $8.32 1/31/20221,110,000 shares $9.99 million +4.7%1.3%2.7 $9.00 1/15/20221,060,000 shares $9.61 million +7.5%1.2%2.7 $9.07 12/31/2021986,000 shares $9.40 million +0.0%1.2%2.4 $9.53 12/15/2021985,700 shares $10.53 million -43.4%1.2%2.4 $10.68 11/30/20211,740,000 shares $26.90 million +4.8%2.0%4.8 $15.46 11/15/20211,660,000 shares $22.83 million -19.8%1.9%5.8 $13.75 10/29/20212,070,000 shares $29.17 million +9.0%2.4%8.6 $14.09 10/15/20211,900,000 shares $27.28 million +8.6%2.2%7.2 $14.36 9/30/20211,750,000 shares $31.29 million +31.6%2.1%7.2 $17.88 9/15/20211,330,000 shares $25.62 million +7.3%1.6%5.4 $19.26 8/31/20211,240,000 shares $23.10 million -0.8%1.5%5.1 $18.63 8/13/20211,250,000 shares $26.74 million -8.8%1.5%3.6 $21.39 7/30/20211,370,000 shares $31.21 million +8.7%1.6%3.6 $22.78 7/15/20211,260,000 shares $34.03 million -10.0%N/A3.6 $27.01 6/30/20211,400,000 shares $41.24 million -5.4%N/A3.8 $29.46 6/15/20211,480,000 shares $41.19 million +42.3%N/A3.8 $27.83 5/28/20211,040,000 shares $28.15 million +5.3%N/A2.6 $27.07 5/14/2021988,100 shares $28.51 million -31.4%1.1%2.8 $28.85 4/30/20211,440,000 shares $43.27 million -9.4%1.7%4.4 $30.05 4/15/20211,590,000 shares $48.50 million +62.5%1.8%4.4 $30.50 3/31/2021978,500 shares $24.73 million +4.6%1.1%2.4 $25.27 3/15/2021935,200 shares $25.33 million +131.7%N/A2.5 $27.09 2/26/2021403,600 shares $14.65 million +8.5%N/A1.2 $36.30 2/12/2021371,900 shares $12.67 million +0.6%0.4%1.2 $34.062025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] 1/29/2021369,700 shares $10.93 million -5.2%0.4%1.4 $29.57 1/15/2021389,800 shares $10.72 million No Change0.5%1.7 $27.50 BNR Short Interest - Frequently Asked Questions What is Burning Rock Biotech's current short interest? Short interest is the volume of Burning Rock Biotech shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 84,000 shares of BNR short. 0.99% of Burning Rock Biotech's shares are currently sold short. Learn More on Burning Rock Biotech's current short interest. What is a good short interest ratio for Burning Rock Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNR shares currently have a short interest ratio of 3.0. Learn More on Burning Rock Biotech's short interest ratio. What is a good short interest percentage for Burning Rock Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.99% of Burning Rock Biotech's floating shares are currently sold short. Is Burning Rock Biotech's short interest increasing or decreasing? Burning Rock Biotech saw a decline in short interest in October. As of October 31st, there was short interest totaling 84,000 shares, a decline of 30.2% from the previous total of 120,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Burning Rock Biotech's float size? Burning Rock Biotech currently has issued a total of 10,240,000 shares. Some of Burning Rock Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Burning Rock Biotech currently has a public float of 8,490,000 shares. How does Burning Rock Biotech's short interest compare to its competitors? 0.99% of Burning Rock Biotech's shares are currently sold short. Here is how the short interest of companies compare to Burning Rock Biotech: Biodesix, Inc. (0.29%), EUDA Health Holdings Limited (0.04%), Quipt Home Medical Corp. (2.17%), P3 Health Partners Inc. (1.37%), Exagen Inc. (0.63%), Enzo Biochem, Inc. (1.31%), Concord Medical Services Holdings Limited (0.48%), OpGen, Inc. (0.19%), Psychemedics Co. (0.31%), The Oncology Institute, Inc. (0.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Burning Rock Biotech stock? Short selling BNR is an investing strategy that aims to generate trading profit from Burning Rock Biotech as its price is falling. BNR shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Burning Rock Biotech? A short squeeze for Burning Rock Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BNR, which in turn drives the price of the stock up even further. How often is Burning Rock Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNR, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Biodesix Short Interest Data EUDA Health Short Interest Data Quipt Home Medical Short Interest Data P3 Health Partners Short Interest Data Exagen Short Interest Data Enzo Biochem Short Interest Data Concord Medical Services Short Interest Data OpGen Short Interest Data Psychemedics Short Interest Data Oncology Institute Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BNR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
